US pharmaceutical company Pfizer last week triumphed in a long-awaited court decision that, if upheld, will stop generics companies from copying its blockbuster cholesterol-lowering drug Lipitor until ...

The pharmaceutical giant Pfizer will to pay a record $2.3 billion settlement for illegal drug promotion. Pfizer Inc. and its subsidiary Pharmacia & Upjohn will pay the settlement to resolve criminal ...

BOSTON (MarketWatch) -- Pfizer shares lost ground Tuesday, following the release of mixed preliminary clinical data for a proposed follow-on product to its blockbuster cholesterol drug Lipitor. Shares ...

The $68 billion acquisition will solidify Pfizer’s standing as the top-selling drugmaker. Bottles of Pfizer’s Lipitor, left, and Wyeth’s Effexor are shown. Shareholders of Wyeth voted overwhelmingly ...

Pfizer received a flurry of attention toward the end of November as its blockbuster statin Lipitor came to the end of its patent protection. Many media outlets were impressed with Pfizer’s aggressive, ...

With it exclusive window on cholesterol drug Lipitor long closed, Pfizer is looking to the post-Lipitor world. WSJ's Spencer Jakab visits Mean Street to make the case that the company's future is ...

March 31, 2011 (San Francisco) — A new analysis of three major trials with atorvastatin (Lipitor, Pfizer) has suggested that the risk of new-onset diabetes with statins appears to be dose dependent ...

Atlanta, GA - With many cardiologists believing that HDL cholesterol is the next major target in the battle against heart disease, the excitement over new HDL-raising drug therapies is growing. One of ...

A new analysis of research data found that a high dose of popular cholesterol pill Lipitor lowers the risk of heart attack and stroke in some patients with both heart disease and kidney disease, the ...